40
In Search of Supply Chain Excellence Lora Cecere of Supply Chain Insights

Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Embed Size (px)

DESCRIPTION

A comparison of progress of two different industries over the course of the last decade.

Citation preview

Page 1: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

In Search of Supply Chain Excellence

Lora Cecere of Supply Chain Insights

Page 2: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 2

Supply Chain Insights is focused on delivering independent, actionable and objective advice for supply chain leaders. A company dedicated to research, turn to us when you want the latest insights on supply chain trends, technologies to know and metrics that matter.

About Us

Page 3: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 3

Over 30 Reports Planned for 2013

#sciwebinar

Page 4: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 4

This is the new bible for all supply chain executives. It provides an insider’s perspective that will prove incredibly valuable to even the most grizzled supply chain veteran. This is the next must-have business book. 

--Bruce Richardson, Chief Enterprise Strategist, Salesforce.com

 

Today, the worlds of social business and supply chain management have many degrees of separation. I enjoyed working with Lora to understand what the future transformation of digital marketing to digital business could look like. 

--Jeremiah Owyang, Research Director, Altimeter 

Second Printing of Bricks Matter: 16 Five-Star Reviews on Amazon

Book can be ordered from Amazon.com in Hardcopy or Digital Format

Page 5: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 5

March 2014 Publication

2013 Publications

#sciwebinar

Page 6: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 6

A Look at History: Progress in Productivity

#sciwebinar

Page 7: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 7

A Look at Retail

Page 8: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 8

Current State: Corporate Social Responsibility

Page 9: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 9

Source: Supply Chain Insights, Corporate Annual Reports 2000-2011

Inventory Performance

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011

Consumer Packaged Goods

59 57 62 64 67 67 68 70 70 64 64 67

Chemical

71.5 71.9 78.2 75.1 62 70.3 68.1 64.3 64.3 78.6 72.9 72.8

Pharma

122.236691097

869

133.699100562

175

190.147616165

968

170.986522478

989

184.342617399

859

175.550260476

877

167.799951139

247

149.815153981

283

154.915781882

591

198.663134119

976

154.313480863

244

131.819794240

294

High Tech

93.1 57.6 46.5 48.5 35.9 37.3 43.8 36.8 34.6 41.3 34.8 30.4

Average

86.4591727744

674

80.0497751405

437

94.2119040414

919

89.6466306197

472

87.3106543499

647

87.5375651192

192

86.9249877848

117

80.2287884953

207

80.9539454706

477

95.6407835299

941

81.5033702158

11

75.5049485600

736

25.0

75.0

125.0

175.0

225.0

Da

ys

o

f In

ve

nto

ry

Page 10: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 10

Current State: Sales and Operations Planning

Page 11: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 11

A Supply Chain

is a Complex System

with Complex Processes

with Increasing Complexity

Page 12: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 12

Trying to Reach Balance

Page 13: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 13

Cross Industry View: (2000-2011)

#sciwebinar

Page 14: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 14

Industry Averages

Page 15: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 15

Consumer Packaged Goods Industry Performance

Page 16: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 16

Three Different Strategies

Page 17: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 17

CPG: An Industry with Leaders

#sciwebinar

Page 18: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 18

Pharmaceutical

Page 19: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 19

Drug Manufacturers- Major (1)

Source: Supply Chain Insights LLC, Corporate Annual Reports 2002-2012 from One Source

200 300 400 500 600 700 8000

1

2

3

4

5

20022012

2002

2012

2002

2012

Bristol-Myers Squibb Co. Eli Lilly & Co. Pfizer Inc.

Revenue per Employee (K$)

Inv

en

tory

Tu

rns

Best Scenario

BMY526, 3.3

PFE500, 1.5

LLY445, 1.7

Average (Revenue per Employee, Inventory Turns)

Page 20: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 20

Healthcare Value Chain Financial Metrics

Page 21: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 21

Industry Progress

Page 22: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 22

Introducing the Supply Chain Index

A formulaic representation of how companies are trading off growth, profitability, cycle and

complexity performance on selected supply chain financial

metrics against market valuation.

#sciwebinar

Page 23: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 23

Selected 14 Core Supply Chain Ratios to Study

Financial Metrics

Growth Profitability Cycle ComplexityCommon Shares Cash Cash-to-Cash Cycle Altman Z

Employee Growth Cash Change in Period Days of Finished Goods Capital Turnover

Employees Cash on Hand Days of Inventory Current Ratio

Market Capitalization Cash Ratio TTM Days of Payables Outstanding Quick Ratio

R&D Margin Cash Ratio Quarter Days of Raw Materials Return on Assets

R&D Ratio Cash Ratio Year Days of Sales Outstanding Return on Equity

R&D to COGS Ratio Cost of Goods Sold Days of Work in Progress Return on Invested Capital

Revenue EBITDA DPO/DSO Return on Net Assets

Revenue Growth Free Cash Flow Ratio Finished Goods Inventory Revenue per Employee

Revenue Growth TTM Gross Margin Inventory Working Capital Ratio

Revenue TTM Gross Profit Inventory Turns

SG&A Margin Net Profit Margin Receivables Turns

SG&A Ratio Operating Cash Flow Ratio Raw Materials Inventory

SG&A to COGS Ratio Operating Margin Work in Progress Inventory

OPEX Ratio

Pretax Margin

Source: Supply Chain Insights LLC

#sciwebinar

Selected Ratios

Page 24: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Summary of Progress

#sciwebinar

Page 25: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 25

Patterns

Page 26: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 26

Healthcare Value Chain

Source: Supply Chain Insights LLC

Metrics That Matter by Industry

Medical Care Industry Medical Distribution Pharmaceutical Major

Free Cash Flow Ratio Operating Margin Free Cash Flow Ratio

Working Capital Ratio Return on Invested Capital Return on Invested Capital

Operating Margin Free Cash Flow Ratio Current Ratio

SG&A to COGS Ratio Working Capital RatioDays of Payables

Outstanding

YoY Revenue Growth Return on Net Assets

Current Ratio DPO/DSO Ratio

Days of Sales Outstanding Current Ratio

Days of Inventory Days of Inventory

Days of Payables Outstanding

0.73 0.84 78

Page 27: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 27

Medical Distribution Equation

Ln(market cap) = 6.04 + 33.39(OM) – 24.69(ROIC) + 15.23(FCF) – 11.11(WC) + 1.49(RONA) + 1.37(DPODSO) +

0.83(CR) + 0.02(DOI)

Correlation Strength

NOTE: Full equation is Ln(market capitalization) =6.036327 + 33.38703(operating margin) -24.6924(return on invested capital) + 15.23431(free cash flow ratio) -11.1125(working capital ratio) + 1.488203(return on net assets) + 1.371671(dpo/dso ratio) + 0.83093(current ratio) + 0.018224(days of inventory)We utilized adjusted which accounts for the occurrence of large p values. Outliers values were defined and excluded as those 5 times larger than IQR.

Medical Distribution Equation

#sciwebinar

Page 28: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 28

Medical Distribution Ranking (2012)

Medical Distribution Ranking (2012)

Rank Company

1 McKesson Corporation

2 Cardinal Health, Inc.

3 Henry Schein Inc.

4 Patterson Companies Inc.

5 Owens & Minor, Inc.

6 MWI Veterinary Supply, Inc.

Source: Supply Chain Insights LLCMorningstar peer group used as basis for equation included, AmerisourceBergen Corp., ALR Technologies Inc. and Chindex International, Inc. for which 2012 results were not available as of 5/15/2013.

#sciwebinar

Page 29: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 29

Medical Distribution Performance Ranking (2012)

Medical Distribution Ranking (2012)

Rank Company CR DOI DPODSO FCF OM ROIC RONA WC Equation Output

1 McKesson Corporation 1.09 31.66 1.91 0.021 0.017 0.065 0.474 0.016

2 Cardinal Health, Inc. 1.24 27.86 1.85 0.008 0.017 0.074 0.210 0.031

3 Henry Schein Inc. 1.84 68.10 0.78 0.040 0.069 0.116 0.259 0.137

4 Patterson Companies Inc.

2.65 49.08 0.45 0.082 0.101 0.131 0.200 0.246

5 Owens & Minor, Inc. 1.76 34.92 1.09 0.020 0.022 0.089 0.122 0.079

Source: Supply Chain Insights LLC, Corporate Annual Reports 2012 from One SourceRankings only include companies that had annual data available through One Source at time of calculation (May 2013).

#sciwebinar

Page 30: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 30

Drug Manufacturers:Major Equation

Ln(market cap) = 9.13 + 10.25(FCF) + 2.88(OM) – 1.20(WC) – 0.71(CR) + 0.01(DOI)

Correlation Strength

NOTE: Full equation is Ln(Market Cap) = 9.129101 + 10.247215 (Free Cash Flow Ratio) + 2.878945 (Operating Margin) – 1.201200 (Working Capital Ratio) – 0.707560 (Current Ratio) + 0.008198 (Days of Inventory)We utilized adjusted which accounts for the occurrence of large p values. Outliers values were defined and excluded as those 5 times larger than IQR.

Drug Manufacturers - Major Equation

#sciwebinar

Page 31: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 31

Major Pharma: 2012

Page 32: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 32

Major Pharma: 2011

Page 33: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 33

Major Pharma: 2010

Page 34: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 34

Major Pharma: 2009

Page 35: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 35

Major Pharma: 2008

Page 36: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 36

• Outside-in• End-to-End Orchestration• Supply Chain Matters

Path Forward

Page 37: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 37

Join Us!

www.supplychaininsightsglobalsummit.com

#sciwebinar

Page 38: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 38

• July 11th: Big Data Supply Chains and the Future of Analytics• August 15th: State of Supply Chain Talent. Missing Link in the

Supply Chain

Upcoming Webinars

Each webinar is based on new and relevant research and will feature two-three industry leaders

Page 39: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 39

Who Is Lora?

• Founder of Supply Chain Insights

• Partner at Altimeter Group (leader in open research)

• 7 years of Management Experience leading Analyst Teams at Gartner and AMR Research

• 8 years Experience in Marketing and Selling Supply Chain Software at Descartes Systems Group and Manugistics (now JDA)

• 15 Years Leading teams in Manufacturing and Distribution operations for Clorox, Kraft/General Foods, Nestle/Dreyers Grand Ice Cream and Procter & Gamble.

Page 40: Pharmaceutical versus Consumer Products: The Race for Supply Chain Excellence

Supply Chain Insights LLC Copyright © 2013, p. 40

Where Do You Find Lora?

Contact Information: [email protected]

Blog: www.supplychainshaman.com (4000 pageviews/month)

Twitter: lcecere 4200 followers.

LinkedIn: linkedin.com/pub/lora-cecere/0/196/573 (3850 in the network)